• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Established Executive and Milwaukee Business Leader Jim Emling Joins VBA as Executive Chair of the Board of Directors

    11/28/23 5:00:00 PM ET
    $DH
    $GDRX
    Computer Software: Prepackaged Software
    Technology
    EDP Services
    Technology
    Get the next $DH alert in real time by email

    Jim Emling, the CEO of Datassential and former long-time president of Milwaukee-based Zywave, has been appointed Executive Chair of the Board of Directors at VBA, the company announced today.

    "We are delighted to welcome Jim officially to VBA as the Executive Chair," said Michael Clayton, the company's President and CEO. "Jim and I have worked closely together over the last 3 months and his decades of experience scaling high growth software companies combined with his strong ties to the Milwaukee technology sector will be tremendous assets to VBA as we enter our next phase of growth."

    Emling has deep roots in the Milwaukee technology community. He was the founding CTO of Zywave and served as its president for 17 years. During his tenure, he led the company from $0 to $100 million in revenue and employed hundreds of people. The Expert Institute, where he currently serves as Board Director, opened an office in the 3rd ward and employs over 75 people in the area. Datassential also has a Milwaukee satellite office.

    Emling joins VBA at a time when the company is heavily investing in sales and product development, having recently closed a growth equity transaction led by Spectrum Equity and Arthur Ventures. Spectrum is a leading growth equity firm that has backed numerous healthcare technology businesses such as Definitive Healthcare (NASDAQ:DH), GoodRx (NASDAQ:GDRX) and Payer Compass (acquired by Zelis).

    VBA makes the health care experience better for everyone by eliminating data fragmentation and enabling interoperability through its tightly integrated suite of solutions. VBA serves the entire payer landscape, including third party administrators (TPAs) and health plans, with its next-gen Core Administrative Processing System ("CAPS"), user engagement platforms, customer support tools, population health reporting solution and robust data connections. The company's cloud-based software solutions enable payers to replace outdated legacy systems, grow their business and reduce costs.

    "It's a really exciting time to join VBA," said Emling. "The company has a reputation for delivering a unique and differentiated software product to customers across the entire healthcare payer landscape. I'm looking forward to helping the company continue to widen its product lead and scale its go-to-market activities."

    About VBA

    VBA is a leading-edge healthcare technology company providing comprehensive software solutions for healthcare payers. Uniquely delivered on a secure, cloud-based platform, VBA provides a suite of technology solutions for core benefits administration. These include a core administrative processing system (VBASoftware), user engagement platforms (VBAGateway), customer support tools (VBAVoice), population health reporting solutions (VBAnalytics) and API-driven data connections (VBAPI). Learn more at https://vbasoftware.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20231128218277/en/

    Get the next $DH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DH
    $GDRX

    CompanyDatePrice TargetRatingAnalyst
    GoodRx Holdings Inc.
    $GDRX
    2/27/2026Overweight → Neutral
    Analyst
    GoodRx Holdings Inc.
    $GDRX
    1/22/2026$2.75Buy → Hold
    Jefferies
    GoodRx Holdings Inc.
    $GDRX
    12/9/2025$3.00Underweight
    Barclays
    GoodRx Holdings Inc.
    $GDRX
    8/11/2025Strong Buy → Outperform
    Raymond James
    Definitive Healthcare Corp.
    $DH
    5/9/2025Buy → Neutral
    BTIG Research
    Definitive Healthcare Corp.
    $DH
    1/13/2025$4.00Equal Weight → Underweight
    Barclays
    Definitive Healthcare Corp.
    $DH
    12/20/2024$5.00Equal-Weight
    Stephens
    GoodRx Holdings Inc.
    $GDRX
    12/4/2024$5.00Neutral
    Mizuho
    More analyst ratings

    $DH
    $GDRX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Heller Casey covered exercise/tax liability with 164,377 shares, decreasing direct ownership by 8% to 1,841,476 units (SEC Form 4) (for tax liability)

    4 - Definitive Healthcare Corp. (0001861795) (Issuer)

    6/3/26 4:05:09 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Coop Kevin covered exercise/tax liability with 66,050 shares, decreasing direct ownership by 1% to 5,012,822 units (SEC Form 4) (tax withholding)

    4 - Definitive Healthcare Corp. (0001861795) (Issuer)

    6/3/26 4:05:03 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Director Hirsch Douglas Joseph was granted 4,642 shares, increasing direct ownership by 2% to 247,502 units (SEC Form 4)

    4 - GoodRx Holdings, Inc. (0001809519) (Issuer)

    5/29/26 5:58:56 PM ET
    $GDRX
    EDP Services
    Technology

    $DH
    $GDRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs

    New $14.99-per-month membership brings together free and low-cost generic medications, affordable online care visits, and savings across dental, vision, labs and imaging Brief Summary: GoodRx launched GoodRx Companion, a new $14.99-per-month subscription to lower everyday healthcare costs Provides access to free and low-cost generic medications, affordable online care, and savings on routine healthcare services Expands GoodRx's subscription strategy as consumers face tighter insurance restrictions and higher out-of-pocket healthcare cost GoodRx (NASDAQ:GDRX), the leading platform for prescription savings in the U.S., today launched GoodRx Companion, a new $14.99-per-month subs

    5/27/26 9:00:00 AM ET
    $GDRX
    EDP Services
    Technology

    Definitive Healthcare advances data platform and integrations to deliver smarter healthcare insights

    FRAMINGHAM, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (NASDAQ:DH), a provider of healthcare data and analytics, today announced several product enhancements designed to give organizations a clearer view of the healthcare ecosystem and help them act on critical market intelligence faster. These updates include expanded medical claims coverage, a new integration for HubSpot, direct access to HCP data within Salesforce, and new AI search capabilities in key products. Together, they strengthen the company's core data foundation and make insights easier to access in the systems teams use every day, helping customers move faster, focus on the right opportunities, and make mo

    5/21/26 9:05:00 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Definitive Healthcare Reports Financial Results for First Quarter 2026

    FRAMINGHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter ended March 31, 2026.  First Quarter 2026 Financial Highlights: Revenue was $55.9 million, a decrease of 6% from $59.2 million in Q1 2025. Net Loss, inclusive of goodwill impairment charges of $197.2 million, was $(192.4) million, or (344)% of revenue, compared to $(155.1) million in Q1 2025, inclusive of goodwill impairment charges of $176.5 million, or (262)% of revenue. Adjusted Net Income was $8.5 million, compared to $7.0 million i

    5/7/26 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    $GDRX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GoodRx downgraded by Analyst

    Analyst downgraded GoodRx from Overweight to Neutral

    2/27/26 8:28:37 AM ET
    $GDRX
    EDP Services
    Technology

    GoodRx downgraded by Jefferies with a new price target

    Jefferies downgraded GoodRx from Buy to Hold and set a new price target of $2.75

    1/22/26 8:25:34 AM ET
    $GDRX
    EDP Services
    Technology

    Barclays initiated coverage on GoodRx with a new price target

    Barclays initiated coverage of GoodRx with a rating of Underweight and set a new price target of $3.00

    12/9/25 8:49:54 AM ET
    $GDRX
    EDP Services
    Technology

    $DH
    $GDRX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Wagner Scott bought $124,806 worth of shares (21,652 units at $5.76) (SEC Form 4)

    4 - GoodRx Holdings, Inc. (0001809519) (Issuer)

    12/4/23 4:35:10 PM ET
    $GDRX
    EDP Services
    Technology

    Wagner Scott bought $180,423 worth of shares (30,505 units at $5.91) (SEC Form 4)

    4 - GoodRx Holdings, Inc. (0001809519) (Issuer)

    11/30/23 4:41:35 PM ET
    $GDRX
    EDP Services
    Technology

    Wagner Scott bought $677,475 worth of shares (130,743 units at $5.18) (SEC Form 4)

    4 - GoodRx Holdings, Inc. (0001809519) (Issuer)

    11/17/23 7:08:30 PM ET
    $GDRX
    EDP Services
    Technology

    $DH
    $GDRX
    SEC Filings

    View All

    SEC Form 8-K filed by Definitive Healthcare Corp.

    8-K - Definitive Healthcare Corp. (0001861795) (Filer)

    6/5/26 4:05:17 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Definitive Healthcare Corp.

    SCHEDULE 13G/A - Definitive Healthcare Corp. (0001861795) (Subject)

    5/14/26 4:18:37 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    SEC Form 144 filed by GoodRx Holdings Inc.

    144 - GoodRx Holdings, Inc. (0001809519) (Subject)

    5/13/26 5:00:10 PM ET
    $GDRX
    EDP Services
    Technology

    $DH
    $GDRX
    Leadership Updates

    Live Leadership Updates

    View All

    GoodRx Appoints Amazon Pharmacy Veteran Laura Jensen as President of Pharma Solutions

    Seasoned industry leader tapped to help pharma reimagine their go-to-market strategies and direct-to-patient models GoodRx (NASDAQ:GDRX), the leading platform for medication savings in the U.S., today announced the appointment of Laura Jensen as Chief Commercial Officer and President of Pharma Solutions, effective July 28, 2025. In this role, Laura will lead the company's Pharma Manufacturer Solutions offering and oversee strategic initiatives aimed at growing and enhancing innovative partnerships across the pharmaceutical industry. Her deep cross-sector experience uniquely positions her to help revolutionize how patients access and afford their medications through the GoodRx platform. T

    7/28/25 9:00:00 AM ET
    $GDRX
    EDP Services
    Technology

    GoodRx Open Sources Lifecycle to Support Innovation in Software Development Velocity and Developer Productivity

    Public release of Lifecycle reflects company's commitment to transparency, innovation, and community collaboration GoodRx (NASDAQ:GDRX), the leading platform for medication savings in the U.S., today announced it is open-sourcing Lifecycle, a homegrown development tool designed to improve team velocity, streamline review workflows, and reduce infrastructure overhead. Lifecycle is now available to the public under the Apache 2.0 license, inviting developers and organizations to adopt, contribute to, and build upon the platform. The tool allows engineering, quality assurance, and platform teams to automatically spin up short-lived, isolated environments—known as ephemeral environments—for

    6/5/25 9:00:00 AM ET
    $GDRX
    EDP Services
    Technology

    GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement

    Accomplished healthcare executives will work to drive growth, strengthen industry partnerships, and enhance pharmacy innovation at GoodRx GoodRx (NASDAQ:GDRX), the leading platform for medication savings in the U.S., today announced the appointment of Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement, effective immediately. Aaron will be responsible for the management and financial performance of GoodRx's Rx Marketplace offering, working with key retail pharmacy, pharmacy benefit manager (PBM), employer, and manufacturer partners. He will also play a critical role in shaping GoodRx's long-term growth strategy

    3/17/25 9:00:00 AM ET
    $GDRX
    EDP Services
    Technology

    $DH
    $GDRX
    Financials

    Live finance-specific insights

    View All

    Definitive Healthcare Reports Financial Results for First Quarter 2026

    FRAMINGHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter ended March 31, 2026.  First Quarter 2026 Financial Highlights: Revenue was $55.9 million, a decrease of 6% from $59.2 million in Q1 2025. Net Loss, inclusive of goodwill impairment charges of $197.2 million, was $(192.4) million, or (344)% of revenue, compared to $(155.1) million in Q1 2025, inclusive of goodwill impairment charges of $176.5 million, or (262)% of revenue. Adjusted Net Income was $8.5 million, compared to $7.0 million i

    5/7/26 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    GoodRx Reports First Quarter 2026 Results

    Pharma Direct Revenue Increased 82% Year-Over-Year in the First Quarter Company Raises Full Year 2026 Revenue and Adjusted EBITDA Expectations GoodRx Holdings, Inc. (NASDAQ:GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading platform for medication savings in the U.S., has released its financial results for the first quarter of 2026. First Quarter 2026 Highlights Revenue of $194.0 million Net income of $1.2 million; Net income margin of 0.6% Adjusted Net Income1 of $23.0 million; Adjusted Net Income Margin1 of 11.9% Adjusted EBITDA1 of $58.3 million; Adjusted EBITDA Margin1 of 30.0% Net cash provided by operating activities of $11.8 million "We deliver

    5/6/26 4:05:00 PM ET
    $GDRX
    EDP Services
    Technology

    Definitive Healthcare Announces Timing of Its First Quarter 2026 Financial Results Conference Call and Webcast

    FRAMINGHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced that it will report financial results for its first quarter ended March 31, 2026, on Thursday, May 7, 2026 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. A live audio webcast of the event will be available on the Definitive Healthcare's Investor Relations website at https://ir.definitivehc.com/. A live dial-in will be available at 877-358-7298 (domestic) or +1-848-488-9244 (international). Shortl

    4/23/26 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    $GDRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by GoodRx Holdings Inc.

    SC 13G/A - GoodRx Holdings, Inc. (0001809519) (Subject)

    11/14/24 12:29:56 PM ET
    $GDRX
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by GoodRx Holdings Inc.

    SC 13G/A - GoodRx Holdings, Inc. (0001809519) (Subject)

    11/13/24 4:30:24 PM ET
    $GDRX
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by GoodRx Holdings Inc.

    SC 13G/A - GoodRx Holdings, Inc. (0001809519) (Subject)

    11/12/24 4:02:41 PM ET
    $GDRX
    EDP Services
    Technology